IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
Dorit Lehmann(Medical University of Vienna), Erhard Hofer, Caterina Sturtzel(Community College of Rhode Island), Marleen Tordoir(Radboud University Nijmegen), Bernhard Schlechta(Medical University of Vienna), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Dirk Groenewegen
Cited by 36
Related Papers
Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack
|Immunity|2015|1.4k
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Endothelial Cell Activation and Thromboregulation during Xenograft Rejection
|Immunological Reviews|1994|211
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
|Clinical Cancer Research|2017|211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
|Frontiers in Immunology|2017|197